Efficacy, Safety and Tolerability of AFQ056 in Patients With Huntington's Disease in Reducing Chorea

NCT01019473 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Huntington's Disease
Chorea

Interventions

DRUG: AFQ056
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals